Morgan Stanley: Underperformance In DowDuPont Provides An Attractive Entry Point
Morgan Stanley Downgrades Albemarle Corp. On Supply, Pricing Concerns
Morgan Stanley: Underperformance In DowDuPont Provides An Attractive Entry Point
Morgan Stanley Downgrades Albemarle Corp. On Supply, Pricing Concerns
Morgan Stanley Resumes Coverage On Praxair As Discussions With Linde Dissolve
Potash Oversupply Makes Investments Uncertain In Short-Term, Morgan Stanley Says
Vincent Andrews Recent News
The Case For Monsanto At $120
UPDATE: Morgan Stanley Upgrades Mosaic Company On Multiple Positive Factors
Morgan Stanley Resumes Coverage On CF Industries
Morgan Stanley Revises Quarterly Estimates For RPM International
Morgan Stanley Sees Challenges Ahead In F2015 For Monsanto Company
Morgan Stanley Believes Strategic Shift In Phosphate Could Trump Negative Preannouncement For Mosaic Co
Morgan Stanley Sees High Quality Growth Story For Monsanto
UPDATE: Morgan Stanley Reiterates On CF Industries As Underperformance Should Begin To Reverse
UPDATE: Morgan Stanley Reiterates on Praxair Ahead of 1Q14 Results
Morgan Stanley Offers Pre-2Q Thoughts on Monsanto Company
UPDATE: Morgan Stanley Resumes Coverage on Agrium with Equal-Weight Rating on Lack of Catalysts
Morgan Stanley Sees Bunge Making Progress Toward Improving Its ROIC
Morgan Stanley is Not Surprised by 4Q Results from Intrepid Potash
Morgan Stanley Thinks Mosaic Shares Have Reacted Favorably to Recent News
Morgan Stanley Fears Expectations on Archer Daniels Midland May Be Too High
Morgan Stanley Reiterates Overweight on Monsanto Company Following F1Q14 Results
UPDATE: Morgan Stanley Resumes Coverage on Potash Corporation on Cautious Market Outlook
UPDATE: Morgan Stanley Downgrades Mosaic Following Potash Industry Shift
UPDATE: Morgan Stanley Maintains Equal-weight on Celanese on Methanol JV Announcements